SPIRALTX.COM: Keyword Density Checker

Total words: 2008 | 2-word phrases: 523 | 3-word phrases: 571 | 4-word phrases: 586

PAGE INFO

Title	Try to keep the title under 60 characters (32 characters) Home – Spiral Therapeutics
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (37 characters) Improving Lives By Protecting Hearing

#	Keyword	Frequency	Density
1	our lead program	3	0.53%
2	the treatment of	3	0.53%
3	and hearing loss	3	0.53%
4	drugs to the	3	0.53%
5	balance disorders and	3	0.53%
6	disorders and hearing	3	0.53%
7	the inner ear	2	0.35%
8	of ménière’s disease	2	0.35%
9	treatment of ménière’s	2	0.35%
10	to the inner	2	0.35%
11	delivery to the	2	0.35%
12	steroid formulation for	2	0.35%
13	sustainedrelease steroid formulation	2	0.35%
14	a sustainedrelease steroid	2	0.35%
15	is a sustainedrelease	2	0.35%
16	spt2101 is a	2	0.35%
17	hugo peris founderceo	2	0.35%
18	to overcome the	2	0.35%
19	drug delivery to	2	0.35%
20	for the treatment	2	0.35%
21	eugene de juan	2	0.35%
22	on balance disorders	2	0.35%
23	of drugs to	2	0.35%
24	read more spiral	2	0.35%
25	focus on balance	2	0.35%
26	ménière’s disease in	2	0.35%
27	spiral is advancing	2	0.35%
28	is advancing a	2	0.35%
29	more spiral therapeutics	2	0.35%
30	with focus on	2	0.35%

#	Keyword	Frequency	Density
1	disorders and hearing loss	3	0.51%
2	balance disorders and hearing	3	0.51%
3	to the inner ear	2	0.34%
4	with focus on balance	2	0.34%
5	delivery to the inner	2	0.34%
6	drug delivery to the	2	0.34%
7	treatment of ménière’s disease	2	0.34%
8	read more spiral therapeutics	2	0.34%
9	for the treatment of	2	0.34%
10	of drugs to the	2	0.34%
11	sustainedrelease steroid formulation for	2	0.34%
12	a sustainedrelease steroid formulation	2	0.34%
13	is a sustainedrelease steroid	2	0.34%
14	spt2101 is a sustainedrelease	2	0.34%
15	on balance disorders and	2	0.34%
16	focus on balance disorders	2	0.34%
17	the treatment of ménière’s	2	0.34%
18	spiral is advancing a	2	0.34%
19	their second ear according	1	0.17%
20	anticipate and manage in	1	0.17%
21	often continue for decades	1	0.17%
22	symptoms often continue for	1	0.17%
23	in middle age and	1	0.17%
24	disease in middle age	1	0.17%
25	ménière’s disease in middle	1	0.17%
26	unilateral ménière’s disease in	1	0.17%
27	with unilateral ménière’s disease	1	0.17%
28	diagnosed with unilateral ménière’s	1	0.17%
29	in general patients are	1	0.17%
30	manage in general patients	1	0.17%
31	and manage in general	1	0.17%
32	to anticipate and manage	1	0.17%
33	for decades over time	1	0.17%
34	difficult to anticipate and	1	0.17%
35	are difficult to anticipate	1	0.17%
36	disrupt daily activities and	1	0.17%
37	patients diagnosed with ménière’s	1	0.17%
38	diagnosed with ménière’s disease	1	0.17%
39	they disrupt daily activities	1	0.17%
40	since they disrupt daily	1	0.17%

#	URL	Whois	Check
1	https://www.linkedin.com/in/hugoperis	Whois	linkedin.com
2	https://ohns.ucsf.edu/charles-limb	Whois	ucsf.edu
3	https://www.linkedin.com/in/jeffrey-sharon-705848124/	Whois	linkedin.com
4	https://www.linkedin.com/in/kyle-peterson-72446a24/	Whois	linkedin.com
5	https://ophthalmology.ucsf.edu/eugene-de-juan-md/	Whois	ucsf.edu